Display options
Cite
Lipshultz SE, Wilkinson JD. Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children. Prog Pediatr Cardiol. 2008;25(1):23-25doi: 10.1016/j.ppedcard.2007.11.003.
Lipshultz, S. E., & Wilkinson, J. D. (2008). Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children. Progress in pediatric cardiology, 25(1), 23-25. https://doi.org/10.1016/j.ppedcard.2007.11.003
Lipshultz, Steven E, and Wilkinson, James D. "Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children." Progress in pediatric cardiology vol. 25,1 (2008): 23-25. doi: https://doi.org/10.1016/j.ppedcard.2007.11.003
Lipshultz SE, Wilkinson JD. Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children. Prog Pediatr Cardiol. 2008 Apr;25(1):23-25. doi: 10.1016/j.ppedcard.2007.11.003. PMID: 19343085; PMCID: PMC2408443.
Copy Download .nbib Format: NLM
Share it on

Prog Pediatr Cardiol. 2008 Apr;25(1):23-25. doi: 10.1016/j.ppedcard.2007.11.003.

Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children.

Progress in pediatric cardiology

Steven E Lipshultz, James D Wilkinson

Affiliations

  1. Department of Pediatrics, Miller School of Medicine, University of Miami, Miami, FL.

PMID: 19343085 PMCID: PMC2408443 DOI: 10.1016/j.ppedcard.2007.11.003

Abstract

This report summarizes the roundtable discussion held at the first International Workshop on Primary and Idiopathic Cardiomyopathies in Children which focused on future directions for research on the epidemiology, etiology and outcomes for children with cardiomyopathy. Areas identified as important for future research included: 1)developing a standardized approach to the assessment and follow-up of children with myocarditis; 2) investigating the epidemiology of sudden death in children with dilated cardiomyopathy; 3) identification of biomarkers to serve as surrogate endpoints for important clinical outcomes; 4) the continuation of observational studies like the National Heart, Lung, and Blood Institute-sponsored Pediatric Cardiomyopathy Registry; and 5) conducting randomized clinical trials of pharmacological and behavioral interventions. It was concluded that optimal research strategies should employ a multidisciplinary research team including pediatric cardiologists, epidemiologists, biostatisticians, geneticists, patient care staff and advocacy groups. Further, adequately powered clinical trials may be facilitated by the establishment of a pediatric cardiomyopathy clinical trials network.

References

  1. Int J Cardiol. 2007 Sep 14;121(1):23-9 - PubMed
  2. Prog Pediatr Cardiol. 2000 Nov 4;12(1):1-28 - PubMed
  3. J Clin Oncol. 2004 Mar 1;22(5):769-73 - PubMed
  4. Mayo Clin Proc. 2006 Feb;81(2):199-204 - PubMed
  5. JAMA. 2007 Sep 12;298(10):1171-9 - PubMed
  6. N Engl J Med. 2003 Apr 24;348(17):1647-55 - PubMed
  7. J Clin Oncol. 2005 Apr 20;23(12):2629-36 - PubMed
  8. N Engl J Med. 2003 Jun 12;348(24):2455-6 - PubMed
  9. Am Heart J. 2000 Feb;139(2 Pt 3):S86-95 - PubMed

Publication Types

Grant support